In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
U.S. GeneMax to use Dutch Crucell's gene technology
Immune Response announces restructuring of license agreement
Infinity announces small molecule collaboration with Amgen
Immune Response reaches agreement with Maryland Biotech Institute
GeneMax licenses technology from NIH for vaccine for smallpox
Immune Response licenses Hybridon's 2nd-generation CpG DNA adjuvant
Immune Response receives two U.S. patents
Immune Response acquires T cell receptor technology
GeneMax and Molecular Medicine BioServices announce production agreement